Start with what life feels like now
Where does SGB fit when POTS limits everyday activity?
We help people with dizziness or a racing heart by examining their symptoms together so that they can work toward standing and walking more confidently.
How we look at the whole picture
Standing in a checkout line or taking a shower can leave you lightheaded, shaky or drained.
You want to do more, but you cannot always predict what your body will tolerate.
You do not need to know which treatment to ask for. Start with what has changed and what you want to be able to do again.
The 7 Domains of Recovery™
Your symptoms may belong in the same conversation.
The autonomic domain looks at responses such as heart rate and tolerance for being upright. We also consider energy, sleep, movement and the other domains that may be affecting your day.
Neuregen's proprietary 7 Domains of Recovery framework organizes that conversation around seven connected parts of your life and health. We consider all seven, then focus the evaluation on the questions your history raises.
Explore our clinical framework- 1Brain function & neural networks
What has changed in your memory, concentration, balance or sensory tolerance?
- 2Autonomic & nervous system regulation
What happens when you stand, move, rest or encounter stress?
- 3Immune function & neuroinflammation
What immune history, reactions or symptoms need a closer look?
- 4Brain energy & metabolic health
What affects your energy through the day and after activity?
- 5Structure, stability & body-to-brain signals
How do pain, posture, movement and stability affect what you can do?
- 6Psychological flexibility & behavioral recovery
How are mood, stress and patterns of coping affecting your day?
- 7Life, relationships & environment
What demands, relationships and support shape your recovery?
A plan starts with the things you want to do again.
We ask when symptoms occur, what makes them worse, how long recovery takes, and what has already been checked. Relevant examination and testing help us decide where to begin.
01
Tell us what you want your life to look like
We start with what has changed, what you have tried, and the activities you most want to return to.
02
Answer the questions the history leaves open
We review prior reports and select relevant assessments. You should understand what each assessment is meant to clarify.
03
Agree on the priorities and the first steps
We discuss the findings, possible approaches, costs and practical constraints. The plan sets an order that fits your situation.
04
Check what changes and adjust together
We compare your response with the starting point, including daily function. If something is not helping, we discuss what needs to change.
Only then do we discuss which therapies, if any, belong in your plan. The choice depends on the findings, the evidence, your preferences and how you respond.
Talk through your situationSGB · POTS & Dysautonomia
SGB for POTS & Dysautonomia
Stellate ganglion block targets the overactive sympathetic output that drives POTS and autonomic dysfunction — not the symptoms alone.
Conceptual artwork for the care discussion. Individual findings and treatment options require clinical evaluation.
Dysautonomia and the sympathetic nervous system
In POTS and autonomic dysfunction, the balance between sympathetic and parasympathetic tone is disrupted. Patients often experience an exaggerated sympathetic response to postural changes — rapid heart rate, lightheadedness, profound fatigue — because the nervous system cannot adequately regulate its own output.
SGB targets this physiology directly. By temporarily interrupting stellate ganglion output, the procedure can reduce chronic sympathetic overdrive and create a window where autonomic regulation becomes possible. At Neuregen, that window is used deliberately: HRV biofeedback, breathing and vagal retraining, graded orthostatic conditioning, and sleep restoration are applied alongside or after the block, so the nervous system learns to hold the regulated state on its own.
Long COVID autonomic symptoms — post-viral dysautonomia, orthostatic intolerance, exercise intolerance — are also candidates for this approach when sympathetic overdrive is the dominant pattern. Candidacy is assessed individually; not every dysautonomia patient is appropriate for SGB.
Domains most involved:
Every plan starts from the same map: the 7 Domains of Recovery.
How it fits your plan
For POTS or dysautonomia, we first review the symptom pattern, prior evaluations and current care. SGB is one option to discuss when appropriate; its place in the plan depends on the clinical findings and evidence.
An injection is worth discussing only when the evaluation identifies a problem it may address. We consider that problem alongside sleep, movement, autonomic symptoms and daily function, then explain what rehabilitation would involve with or without the procedure.
We review your history, explain the findings, agree on next steps and check how you respond.
Potential Therapies
We use established medicine where it works, and emerging medicine where it makes sense.
These are options to discuss after evaluation, not a predetermined treatment plan. Each label refers to the condition or indication described beside that therapy; evidence can differ for another use. An evidence label does not mean FDA approval.
- Stellate Ganglion BlockEvidence: Preliminary
Preliminary evidence for dysautonomia and POTS; not yet a standard of care for this indication.
- HRV biofeedback and autonomic calibrationEvidence: Established
Applied alongside or after SGB to build on the regulatory window.
- Orthostatic vitals monitoring
Pre- and post-procedure assessment to quantify autonomic response.
Where the evidence stands
SGB for dysautonomia and POTS is a preliminary indication. Published reports are early and largely uncontrolled, though the mechanistic rationale is clear — the procedure targets the sympathetic chain directly. It is not yet a standard of care for this indication.
Sources and what they support
- VA/DoD clinical practice guideline for PTSD
Recommendation 24 finds insufficient evidence to recommend for or against stellate ganglion block for PTSD. A proposed mechanism is not proof of benefit.
How we grade evidence
Pricing
| Service | Price |
|---|---|
| Stellate ganglion block, single (unilateral) | Confirmed in writing at your Strategy Consultation |
| Stellate ganglion block, bilateral | Confirmed in writing at your Strategy Consultation |
| SGB series within an autonomic-regulation programNumber of blocks set by response, not a fixed package | Confirmed in writing at your Strategy Consultation |
Neuregen is an out-of-network specialty clinic. Most therapies listed here are not covered by insurance; we provide itemized documentation you can submit to your insurer, and we tell you before any therapy which parts, if any, are typically reimbursed.
Financing options are reviewed at your Strategy Consultation before any plan is finalized.
The training behind this care
At Neuregen, the injection discussion sits inside a rehabilitation plan. Our team connects the proposed procedure to findings, practical goals and follow-up instead of treating the procedure as the whole course of care.
Dr. David George: Board certifications and training in functional neurology, integrative psychiatry, and mental health; certified brain injury specialist.
Training most relevant to this area
- Certified Clinical Trauma Professional (CCTP)
- PMHNP-BC
These are the founder’s qualifications. We confirm the treating clinician and their role when discussing your plan.
See Dr. George’s full credentialsFrequently asked questions
Why would SGB help with POTS?
POTS involves an autonomic nervous system that cannot adequately regulate its own sympathetic output — particularly in response to postural change. SGB temporarily interrupts the stellate ganglion, a key relay in the cervical sympathetic chain. This can reduce the exaggerated sympathetic activation that drives POTS symptoms. The effect is physiological rather than symptomatic: SGB targets the mechanism, not the downstream consequences.
Is SGB a standard treatment for POTS?
No. SGB for POTS and dysautonomia carries a preliminary evidence level — early reports and active investigation, but not yet a standard of care for this indication. We discuss the current evidence base with each patient at the Strategy Consultation before any treatment is recommended.
Does long COVID dysautonomia respond to SGB?
Post-viral autonomic dysfunction, including the orthostatic intolerance and hyperadrenergic patterns seen after COVID-19, may involve the same sympathetic overdrive mechanism that SGB addresses. Candidacy for SGB in this population is assessed individually — not every long COVID patient with autonomic symptoms is appropriate for the procedure.
What else does Neuregen use alongside SGB for POTS?
SGB creates a window of reduced sympathetic output. Neuregen uses that window to layer in autonomic rehabilitation: HRV biofeedback, orthostatic conditioning, and structured physical reconditioning. The goal is to build on the regulatory state the injection creates, not to rely on repeated blocks as the sole intervention.
How is the outcome measured?
Neuregen uses objective pre- and post-procedure measures: orthostatic vitals (heart rate and blood pressure response to positional change), HRV (heart rate variability), and patient-reported autonomic symptom burden. These are tracked across the program, not just immediately after the procedure.
Start with a Strategy Consultation
If symptoms keep interrupting work, sleep or movement, that disruption is already part of your day. A consultation can help clarify the next question to investigate; it does not commit you to an injection.
8090 N. 85th Way, Suite 100, Scottsdale, AZ 85258 · Mon–Thu, 9:00 AM – 5:30 PM